NCT03928327View on ClinicalTrials.gov

A Study to Evaluate Drug-Drug Interaction of TAK-788 With Itraconazole and Rifampin in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

August 16, 2019

Study Completion Date

August 16, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-788

TAK-788 Capsules

DRUG

Itraconazole

Itraconazole Oral solution

DRUG

Rifampin

Rifampin Capsules

Trial Locations (1)

85283

Celerion, Tempe

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY